# OnCo record paper-ctrak-tn-tissue-free-mrd-jamaoncol-2026 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-ctrak-tn-tissue-free-mrd-jamaoncol-2026/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-ctrak-tn-tissue-free-mrd-jamaoncol-2026" ;
  schema:name "c-TRAK TN analysis: tissue-free versus tumour-informed ctDNA assays for residual disease in early triple-negative breast cancer"@en ;
  schema:description "A blood test that needs no tumour sample found leftover cancer DNA in a third of women after treatment for triple-negative breast cancer, and those women were far more likely to relapse; it agreed closely with the tests that first sequence the tumour."@en ;
  schema:url <https://onco.cc/key-papers/paper-ctrak-tn-tissue-free-mrd-jamaoncol-2026/> ;
  schema:dateModified "2026-09-21"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2026.2833>, <https://pubmed.ncbi.nlm.nih.gov/42593771/> ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2026.2833> ;
  schema:datePublished "2026"^^xsd:gYear ;
  schema:author "Cunningham N, Cutts RJ, Swift C, et al." ;
  onco:cancers <https://onco.cc/cancers/tnbc/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/mrd-testing/> ;
  onco:terms <https://onco.cc/terms/tumour-informed-assay/>, <https://onco.cc/terms/mrd/>, <https://onco.cc/terms/ctdna/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .